SASH1
protein-codingSAM and SH3 domain containing 1, the group of SAM and SH3 domain containing|Sterile alpha motif domain containing
Gene summary
This gene encodes a scaffold protein involved in the TLR4 signaling pathway that may stimulate cytokine production and endothelial cell migration in response to invading pathogens. The encoded protein has also been described as a potential tumor suppressor that may negatively regulate proliferation, apoptosis, and invasion of cancer cells, and reduced expression of this gene has been observed in multiple human cancers. Mutations in this gene may be associated with abnormal skin pigmentation in human patients. [provided by RefSeq, Oct 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~279.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007891
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018657
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0018657
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0024524
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0024524
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0018657
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Dental; Dermatologic; Oncologic
Intervention: Oncologic
Rationale: The condition can involve the development of squamous cell carcinomas, and awareness may allow surveilance in order to allow prompt diagnosis and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SASH1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015278.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 39 | 42 | |||
| missense | 14 | 226 | 21 | 3 | 264 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 8 | 8 | ||||
| Total | 1 | 14 | 238 | 60 | 3 | 316 |
Highest pathogenic variant AF is 0.000032838525
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056093.3 | 20 | MANE Select | |
| Ensembl | ENSP00000356437.3 | 20 | MANE Select | |
| RefSeq | NP_001333434.1 | 20 | Standard | |
| RefSeq | NP_001333435.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- protein polyubiquitination
- positive regulation of endothelial cell migration
- positive regulation of lipopolysaccharide-mediated signaling pathway
- positive regulation of JUN kinase activity
- positive regulation of angiogenesis
Molecular Function
- protein C-terminus binding
- protein kinase binding
- mitogen-activated protein kinase kinase kinase binding
- protein-containing complex scaffold activity
Cellular Component
- protein-containing complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367467
- Coding exons
- 20
- Length
- 279747
- Individuals with no LoFs
- 125700
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 48
- Defined
- 125748
- p
- 0.000191
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.604 | 701 | 747 | 0.938 | 0.0000463 | 8082 |
| Missense (PolyPhen) | 252 | 314.69 | 0.80079 | 3414 | ||
| Synonymous | -0.505 | 327 | 316 | 1.04 | 0.0000219 | 2512 |
| Loss of Function | 4.89 | 16 | 55.2 | 0.290 | 0.00000289 | 688 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00044 | 0.00043 | rare |
| Latino/Admixed American | 0.00032 | 0.00032 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00034 | 0.00033 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00016 | 0.00016 | rare |
| South Asian | 0.00014 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May have a role in a signaling pathway. Could act as a tumor suppressor.;
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- LoFtool
- 0.521
- RVIS EVS
- -0.56
- RVIS percentile EVS
- 19.07
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.867
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | High | Medium | High |
| Cancer | High | Medium | High |